| scholarly article | Q13442814 |
| P2093 | author name string | Danai Tavonga Zhou | |
| Denise Mudzinge | |||
| Tawanda Jonathan Chisango | |||
| Tinashe Kenny Nyazika | |||
| P2860 | cites work | Systematic Review: Vitamin D and Cardiometabolic Outcomes | Q22305327 |
| Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques | Q28775900 | ||
| Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users | Q34213832 | ||
| Decrease of vitamin D concentration in patients with HIV infection on a non nucleoside reverse transcriptase inhibitor-containing regimen | Q34403352 | ||
| HIV infection--a risk factor for osteoporosis | Q35169981 | ||
| Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy | Q35208120 | ||
| Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study | Q35744467 | ||
| Hypophosphatemic Osteomalacia Associated with Tenofovir: a Multidisciplinary Approach is Required. | Q36033710 | ||
| Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature | Q36204603 | ||
| Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study. | Q40005044 | ||
| Tenofovir nephrotoxicity: 2011 update | Q42254390 | ||
| Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study | Q42912276 | ||
| Hypomagnesemia is a risk factor for nonrecovery of renal function and mortality in AIDS patients with acute kidney injury | Q43094558 | ||
| Reduced bone mineral density in HIV-infected patients: prevalence and associated factors | Q44427873 | ||
| The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients | Q44787744 | ||
| Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice | Q45285932 | ||
| First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir. | Q46021020 | ||
| Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART | Q58812163 | ||
| Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population | Q64129102 | ||
| Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART | Q80923851 | ||
| Cofactors for low serum albumin levels among HIV-infected individuals in Southern India | Q83256235 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | magnesium | Q660 |
| Zimbabwe | Q954 | ||
| opportunistic infection | Q835718 | ||
| P304 | page(s) | 383214 | |
| P577 | publication date | 2013-09-04 | |
| P1433 | published in | ISRN AIDS | Q27725040 |
| P1476 | title | Differences in Serum Levels of Magnesium, Phosphate, and Albumin for HAART-Experienced and HAART-Naïve Female Patients Attending Parirenyatwa Opportunistic Infections Clinic in Harare, Zimbabwe | |
| P478 | volume | 2013 |
| Q58776477 | Combination ART-Induced Oxidative/Nitrosative Stress, Neurogenic Inflammation and Cardiac Dysfunction in HIV-1 Transgenic (Tg) Rats: Protection by Mg |
| Q35618069 | Dyslipidemia and cardiovascular disease risk profiles of patients attending an HIV treatment clinic in Harare, Zimbabwe |
Search more.